688393.SS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 03:00):

Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China...

Stats
Today's Volume	890 654
Average Volume	1.78M
Market Cap	1.62B
EPS	CNY0.213 ( 2023-10-30 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	41.12
ATR14	CNY0.0180 (0.10%)

Volume Correlation

Long: -0.33 (neutral)

Short: -0.72 (moderate negative)

Signal:(37.792) Neutral

Guangzhou LBP Medicine Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Guangzhou LBP Medicine Correlation - Currency/Commodity

-0.73
( moderate negative )

-0.86
( strong negative )

0.00
( neutral )

-0.93
( very strong negative )

0.22
( neutral )

0.20
( neutral )

Guangzhou LBP Medicine Financials

Annual	2023
Revenue:	CNY497.29M
Gross Profit:	CNY473.93M (95.30 %)
EPS:	CNY0.430

Q4	2023
Revenue:	CNY142.78M
Gross Profit:	CNY95.12M (66.62 %)
EPS:	CNY0.0291

Q3	2023
Revenue:	CNY143.55M
Gross Profit:	CNY94.08M (65.53 %)
EPS:	CNY0.210

Q2	2023
Revenue:	CNY120.21M
Gross Profit:	CNY86.96M (72.34 %)
EPS:	CNY0.110

Financial Reports:

No articles found.

Guangzhou LBP Medicine

Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China. It offers pathological diagnostic reagents and ancillary equipment, including liquid-based cytology, such as gynecological series, non-gynecological series, and equipment; fluorescence in situ hybridization products for various applications in breast, bladder, lung, cervical, prostate, and thyroid cancer; and neuroblastoma, soft tissue sarcoma, other solid tumors, prenatal screening and abortion, oligodendrocytes tumor, lymphoma, multiple myeloma, chronic myelogenous and lymphocytic leukemia, myelodysplastic syndromes, acute myeloid leukemia, and acute lymphoblastic leukemia. The company also provides immunohistochemistry products, which comprise antibodies, detection systems, repair systems, complementary products, and immunohistochemistry kit, as well as molecular genetic diagnosis products. Guangzhou LBP Medicine Science & Technology Co., Ltd. was founded in 2005 and is based in Guangzhou, China.